• Journal of Korean Neurosurgical Society
• /
• 제46권3호
• /
• pp.221-225
• /
• 2009

Objective : Surgical treatment of posterior inferior cerebellar artery (PICA) aneurysms is challenging due to limited surgical accessibility. Endovascular approach has a benefit of avoiding direct injury to the brainstem or lower cranial nerves. Therefore, it has recently been considered an alternative or primary modality for PICA aneurysms. We retrospectively assessed outcomes following detachable coil embolization of saccular PICA aneurysms. Methods : From February 1997 to December 2007, we performed endovascular procedures to treat 15 patients with 15 PICA aneurysms. Fourteen patients with 14 PICA aneurysms morphology of which was saccular were reviewed retrospectively. Twelve patients had ruptured aneurysms. The aneurysms arose from the PICA origin site (n=12), the PICA lateral medullary segment (n=1), or the PICA tonsilomedullary segment (n=1). Results : Complete aneurysm occlusion was achieved in 10 patients, residual neck in 3, and residual sac in one. Radiological follow-up was performed in 7 patients with mean duration of 34.7 months (range, 1-97 months) and showed stable or complete occlusion in 6 patients. There were no rebleeding or retreatment after endovascular treatment. Thromboembolism was the only procedure-related complication (n=4 ; 28.6%). Asymptomatic PICA infarction occurred in two patients and symptomatic PICA infarction in two elderly patients with poor clinical grade. Of these procedural PICA infarction cases, 1 symptomatic PICA infarction patient developed ventriculitis and septic shock leading to death. The clinical outcome was good in 10 patients (71.4%). Conclusions : In the present study, detachable coil embolization has shown as an efficient modality for PICA saccular aneurysms challenging indications of microsurgery. However, thromboembolic complications should be considered, especially in poor clinical elderly patients with ruptured aneurysms.

• Journal of Korean Neurosurgical Society
• /
• 제39권4호
• /
• pp.286-291
• /
• 2006

Objective : We evaluate the effect of the copolymer-coated coils on immediate occlusion of the aneurysm, preventing rupture, and decreasing compaction or re-growth. Methods : Thirty-five aneurysms treated between September 2003 and December 2004 using Matrix detachable coil were reviewed. Study population consisted of 12 men and 23 women ranging in age from 34 to 75 years[mean, 55.1 years]. Twenty-two aneurysms were ruptured and 23 aneurysms were located in the anterior circulation. Follow-up angiography was obtained in 16 patients after 6 months from the procedure. Results : Initial complete occlusion was achieved in 17 aneurysms[48.6%], and the others remained as a residual neck in 8 aneurysms[22.8%] and residual sac in 10 aneurysms[28.6%]. Among these incompletely occluded aneurysms, 7 aneurysms were performed follow-up angiography. And 6 of them converted into complete occlusion. In the other hands, among 17 aneurysms achieved complete occlusion initially, 9 aneurysms were performed follow-up angiography. Recurrence due to coil compaction occurred in one aneurysm and the others maintained complete occlusion. There was one mortality case due to thromboembolic complication. Conclusion : In spite of difficulty in achieving complete occlusion with Matrix coil system, there is no rupture or re-rupture during follow-up period. Follow-up angiography shows many conversions of residual sac into complete occlusion. Embolization using Matrix coil system is safe and effective, but the effects of PGLA copolymer need further investigation.

• Journal of Chest Surgery
• /
• 제56권2호
• /
• pp.90-98
• /
• 2023

Background: Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. Totally thoracoscopic ablation (TTA) is a surgical treatment showing a high success rate as a hybrid procedure with radiofrequency catheter ablation to control AF. This study compared the early complications of warfarin and non-vitamin K antagonist oral anticoagulants (NOACs) in patients who underwent TTA. Methods: This single-center retrospective cohort study enrolled patients who underwent planned TTA for AF from February 2012 to October 2020. All patients received postoperative anticoagulation, either with warfarin or a NOAC (apixaban, rivaroxaban, dabigatran, or edoxaban). Propensity score matching was performed for both groups. Early complications were assessed at 12 weeks after TTA and were divided into efficacy and safety outcomes. Both efficacy and safety outcomes were compared in the propensity score-matched groups. Results: Early complications involving efficacy outcomes, such as stroke and transient ischemic attack, were seen in 5 patients in the warfarin group and none in the NOAC group. Although the 2 groups differed in the incidence of efficacy outcomes, it was not statistically significant. In safety outcomes, 11 patients in the warfarin group and 24 patients in the NOAC group had complications, but likewise, the between-group difference was not statistically significant. Conclusion: Among patients who underwent TTA, those who received NOACs had a lower incidence of thromboembolic complications than those who received warfarin; however, both groups showed a similar bleeding complication rate. Using a NOAC after TTA does not reduce efficacy and safety when compared to warfarin.

• Journal of Chest Surgery
• /
• 제31권6호
• /
• pp.591-597
• /
• 1998

배경: 이 연구의 목적은 대동맥판막 치환술의 조기 및 중기의 결과를 분석하였다. 대상 및 방법 : 1986년 1월부터 1996년 1월까지 대동맥판막 치환술을 시행한 61명의 환자를 대상으로 하였다. 남자가 38명이었고 여자는 28명으로 남녀의 비는 1.7:1로 남자에 많았고 연령분포는 10세에서 71세까지로 평균 40.5$\pm$11.2세이었다. 조기 사망률은 4.9%(3/61)이었다. 전체적인 추적 관찰은 퇴원한 58명의 환자 중 93.1%에서 이루어 졌으며 평균 추적기간은 51.5 환자-달이었다. 결과: 퇴원한 환자 58명 중 3명이 사망하여 만기 사망률은 5.2 %이었다. 5명의 환자에서 항응고제에 관련된 출혈이 있었으나 모두 경미하였고 3명의 환자에서 혈전경색을 보였다. 용혈이나 사용된 판막의 구조적인 실패는 없었고, 생존한 환자 중 NYHA 기능등급은 의의있게 호전되었다. 혈전경색과 항응고제에 관련된 출혈률은 각각 1.58 % 환자-년, 2.0% 환자-년이었다. 10년 생존률은 83.6%를 보였다. 결론 : 조기 및 중기의 추적관찰에서 대동맥판막 치환술에 사용한 기계판막은 낮은 인공판막에 연관된 합병증과 훌륭한 혈역학적 기능을 보이고 신뢰성이 있으면서 내구성이 좋은 인공판막이라 할 수 있었다.

• Journal of Chest Surgery
• /
• 제29권10호
• /
• pp.1090-1094
• /
• 1996

연세대학교 심장혈관센터에서는 1980년 2월부터 1995년 9월까지 승모판질환을 가진 2개월부터 15세 가지의 소아환자 31명에게 승모판치환술을 시행하였다. 이중 추적조사가 가능했던 환자는 28명이었으며, 남아는 10명, 여아는 18명이었고, 체중은 4.9kg부터 5.6kg까지 였다. 조기사망은 2례(7.1%)에서 발생하였고, 이들은 모두 1세이하의 영아였으나, 각 연령군사이의 사망률은 통계학적으로 의미 있는 차이는 없었다(p=0.13). 5세이하의 소아에서 판막과 관련된 합병증률은 57.1%였으며, 다른 연령군에 비해 승모판치환술후 높은 합병증률을 보여주었다(p<0.05). 조직 판막을 사용하였던 소아환자는 모두 7명이며, 그들의 판막실패 없는 5년 생존률은 50%이었다. 기계 판막을 사용하였던 나머지 21명의 환자에서 아직 판막실패는 발생하지 않았다. 조직 판막의 높은 재치환률을 생각해볼 때, 기계판막은 항응고제가 필요하고, 출혈과 혈전색 전증 가능성 이 있지만, 내구성 이 짧은 조직판막보다는 좋다. 그러나, 자라나는 심장내에 장기간 삽입된 기계판막은 성장함에 따라 재치 환술을 필요로 할 것으로 생각된다. 소아에서의 승모판치환술은 만족할 만한 장기\ulcorner적을 보여주고 있지만, 사망률과 합병증률에 영향을 미치는 중요한 요소는 소아의 연령이다. 특히 5세이하의 환아에서는 승모판치환술시 세심한 주의를 요한다.

• Journal of Chest Surgery
• /
• 제25권5호
• /
• pp.494-503
• /
• 1992

The durability of the xenograft cardiac substitute valves is of a great concern on the clinical grounds. Four groups of tc tal and consecutive patients to the end of study operated on between 1976 and 1984 were Group ISM, 291 patients of MVR, ISA, 65 patients of AVR, and ISMA, 107 patients of MVR+AVR with the standard Ionescu-Shiley bovine pericardial valve, and H, 163 patients of valve replacement with the Hancock porcine aortic vlave. Operative mortality was 5.2%[ISM], 10.8%[ISA], 7.5%[ISMA] and 6.1%[H]. Early survivors were followed up for a total of 1148.3 patient-years[pt-yrs] [ISM], 271.2 pt-yrs [ISA], 488.1 pt-yrs[ISMA] and 822.9 pt-yrs[H]. Linearized late mortality was 2.1% /pt-yr [ISM], 1.l%/pt-yr[ISA], 1.8%/pt-yr[ISMA] and 1.8% /pt-yr[H]. Thromboembolic complication was experienced at the linearized rate of 1.045% /pt-yr [ISM], 1.475%/pt-yr[ISA], 0.615%/pt-yr[ISMA] and 1.822%/pt-yr[H], and bleeding complication at the rate of 0.871% /pt-yr[ISM], 0.63% /pt-yr[ISA], 0.205% /pt-yr [ISMA] and 0.729%a /pt-yr[H], respectively. Prosthetic valve endocarditis occurred at the rate of 0.610% /pt-yr[ISM], 1.475% /pt-yr[ISA], 1.639% /pt-yr[ISMA] and 0.972% /pt-yr[H]. The linearized annual incidence of primary tissue failure was 1.655%/pt-yr[ISM], l. 475%/pt-yr[ISA], 1.639% /pt-yr[ISMA], 2.187% /pt-yr[H] and 1.785% /pt-yr[Group HM : MVR with Hancock valve]. The incidence of tissue failure was significantly high in the patients younger than 30 years of age compared with the older patients. The actuarial survival was 87.7$\pm$2.5% at 10 years[ISM], 94.3$\pm$3.2% at 11 years[ISA], 89.6$\pm$3.4% at 10 years[ISMA] and 81.3$\pm$6.6% at 12 years[HM], The freedom from thromboembolism was 93.2$\pm$2.0% at 10 years[ISM], 90.6$\pm$4.6% at 11 years[ISA], 95.8$\pm$2.6% at 10 years[ISMA] and 80.9$\pm$11.1% at 12 years[HM], And, the freedom from primary tissue failure was 84.2$\pm$3.8% and 28.1$\pm$23.0% at 9 and 10 years[ISM], 60.4$\pm$16.9% at 11 years[ISA], 62.3$\pm$12.7 at 10 years[ISMA] and 65.6$\pm$9.8% at 12 years[HM]. In conclusion, the standard Ionescu-Shiley and the Hancock bioprosthetic valves are excellent in their antithrombogenicity and long-term survival. However, the features of the structural failure with the prolonged follow-up beyond 10 years appear to be guarding, and the clinical indications of these bioprostheses seem to be quite limited.

• Journal of Chest Surgery
• /
• 제29권10호
• /
• pp.1095-1101
• /
• 1996

1983년 7월부터 1995년 6월까지 전북대학교병원 흉부외과학 교실에서 승모판협착증으로 수술을 시행한 판막치환술 62예와 교련절개술 33예를 패상으로 하였다. 대동맥 판막이나 관상동맥 질환을 동반하거나 중등도 이상의 승모판 폐쇄부전증이 동반된 경우는 본 연구에서 제외하였으며 승모판 협착증에 대한 술식들을 합병증과 재수술, 사망율, 수술후 기능적인 변화에 따라 비교 분석 하였다. 수술전 대상환자의 특성 중 승모판 치환술군에서 심흉곽비가높았던 점 이외에 나이나 성별, NYHA 기능분류, 심전도상 심방세동의 유무, 심초음파 소견에서 두군 간에 의의 있는 차이는 없었다. 수술시 판막 병변의 병리학적 소견은 치환술군에서 더 심하였고(Sellors type IR, 35 in MVR, 1) in OMC 3 판엽의 석회화를 보이는 경우도 많았으나(35 in MVR, 11 in OMC), 판엽의 석 회화가 있었던 46 예 중 11예(23.9%)와 Sellor의 제3형 협착 61예 중 13예(27.1 %)에서 교련절개 술이 가능하였다. 수술후 조기 및 만기사망과 생존율에서 두군 간에 차이는 없었고, 출혈 및 혈전색전증과관련된 조기 및 만기 합병증이 치환술군에서 더 많았으며, 수술후 중장기 추적관찰시 N HA기능분류, EKG, 심흉 곽비, 심초음파 소견(EF, LAD, LWDs, LWDd) 등의 기능상의 변화에서는 두군간에 의의있는 차이를 발견할 수 없었다. 승모판 헙착증의 상호 보완적인 주요술식인 치환술과 교련절개술은 술식에 따른 기능상의 변화와 사망 및 생존율에 의의있는 차이는 없으나 출혈 및 혈전색전증과 관련된 합병증이 치환술군에서 많았고 고도의 협착 및 판막석회화가 존재하는 상황에서도 교련절개술이 가능하였으므로 자연판막의 보전을 위한 노력은 지속되어야 한다.

• Clinical and Experimental Pediatrics
• /
• 제50권6호
• /
• pp.588-591
• /
• 2007

좌심실 혈전은 전벽 심근 경색이나 심한 심첨부 심벽 운동 이상에 의해 주로 발생하며, 매우 드물게 급성 심근염에 합병되어 나타날 수 있다. 급성 심근염에 의한 혈전 형성은 심내막 손상 및 혈액의 울혈과 관계가 있는 것으로 생각되고 있다. 좌심실 혈전이 유동적이고 유경성일 경우, 전신 색전증의 위험이 증가하는 것으로 알려져 있다. 혈전이 무경성이고 유동성이 없는 경우에는 항응고 치료 요법을 고려할 수 있지만, 유경성의 과유동성 혈전이어서 전신 색전증의 가능성이 높거나 이미 전신 색전증이 발생한 경우에는 색전증의 재발을 막기 위해서 신속한 수술적 혈전 제거술이 필요하다. 저자들은 급성 심근염에 의해 생긴 좌심실 혈전을 수술적 치료로 제거하였기에 보고하고자 한다.

• Journal of Chest Surgery
• /
• 제48권5호
• /
• pp.328-334
• /
• 2015

Background: There have been a number of studies on mitral valve replacement and repeated percutaneous mitral balloon valvotomy for mitral valve restenosis after percutaneous mitral balloon valvotomy. However, studies on mitral valve repair for these patients are rare. In this study, we analyzed postoperative outcomes of mitral valve repair for mitral valve restenosis after percutaneous mitral balloon valvotomy. Methods: In this study, we assessed 15 patients (mean age, $47.7{\pm}9.7years$; 11 female and 4 male) who underwent mitral valve repair between August 2008 and March 2013 for symptomatic mitral valve restenosis after percutaneous mitral balloon valvotomy. The mean interval between the initial percutaneous mitral balloon valvotomy and the mitral valve repair was $13.5{\pm}7years$. The mean preoperative Wilkins score was $9.4{\pm}2.6$. Results: The mean mitral valve area obtained using planimetry increased from $1.16{\pm}0.16cm^2$ to $1.62{\pm}0.34cm^2$ (p=0.0001). The mean pressure half time obtained using Doppler ultrasound decreased from $202.4{\pm}58.6ms$ to $152{\pm}50.2ms$ (p=0.0001). The mean pressure gradient obtained using Doppler ultrasound decreased from $9.4{\pm}4.0mmHg$ to $5.8{\pm}1.5mmHg$ (p=0.0021). There were no early or late deaths. Thromboembolic events or infective endocarditis did not occur. Reoperations such as mitral valve repair or mitral valve replacement were not performed during the follow-up period ($39{\pm}16months$). The 5-year event-free survival was 56.16% (95% confidence interval, 47.467-64.866). Conclusion: On the basis of these results, we could not conclude that mitral valve repair could be an alternative for patients with mitral valve restenosis after percutaneous balloon mitral valvotomy. However, some patients presented with results similar to those of mitral valve replacement. Further studies including more patients with long-term follow-up are necessary to determine the possibility of this application of mitral valve repair.

• Journal of Chest Surgery
• /
• 제27권4호
• /
• pp.272-280
• /
• 1994

Total 400 St.Jude Medical Bileaflet Valves were implanted in 336 pts from January 1983 to June 1993; 64 were aortic, 205 were mitral, 64 were double valve and 3 were tricuspid position. The follow up period extended from 6 months to 10 years[mean 24.3 months]. Male to female ratio was 1:1.7. There were total 27 deaths[cardiac related 20, cardiac non-related 7]. Overall mortality was 2.9%/pt-yr. There were 10 early deaths[3.0%] and 10 late cardiac related deaths [3.0%]. Prosthetic valve related complications occurred in 19 patients[5.7%] and among them, seven died; four died of thromboembolic events, two died of anticoagulants therapy related hemorrhagic complications and one died of bacterial endocarditis. NYHA class improved significantly especially in aortic valve replacement and double valve replacement. In AVR cases, the mean NYHA was 2.8 preoperatively and 1.3 postoperatively. And in DVR cases, 3.3 preoperatively and 2.2 postoperatively. The decision to employ a particular prosthesis was made according to the anticipated or known complications of the valve. The St.Jude Medical Valve retains all the hazards of other mechanical valves, most notably, thromboembolism. But the hemodynamic performance of St.Jude Medical Valve compared most favorably with other substitute valves in many reports. 0ur experience didn`t show any differences compared other authors in terms of valve related complication. So we concluded St. Jude Medical Valve can be primarily considered in the selection of artificial valve except in the patients when the usage of anticoagulant therapy is contraindicated.